Custom Software

Agentic AI in Healthcare: Tool-Using AI for Multi-Step Clinical and Administrative Workflows

Agentic AI in healthcare is the application of large language models to multi-step workflows where the AI plans a task, calls tools (APIs, EHR endpoints, payer systems, clinical databases) to gather information or take action, evaluates intermediate results, and iterates toward an outcome. Production-grade agentic AI in healthcare requires tool-call allowlists, deterministic guardrails on consequential actions, human-in-the-loop confirmation at clinical and financial decision points, BAA paper trail spanning every tool the agent calls, audit logging of every plan-execute-evaluate cycle, and architecture that keeps the agent below the FDA SaMD threshold by routing all clinical decisions through a clinician.

Agentic AI is the fastest-emerging category in healthcare AI in 2026. It is also the category where the gap between vendor demos and production deployments is widest. A well-designed agentic system can collapse a 30-minute prior-auth workflow into a 3-minute clinician review. A poorly-designed one can take a clinically-incorrect action across a payer system or an EHR with consequences that are extraordinarily expensive to unwind.

The architectural decisions that separate the two are clear. Taction Software® has built agentic AI for prior authorization, claims status follow-up, scheduling automation, intake processing, eligibility verification, and revenue-cycle workflow orchestration — for healthtech founders, hospital innovation teams, and enterprise health systems. This page is the engineering and decision framework.

Calculate My Project Cost Connect With Experts

Tell Us Your Requirements

Our experts are ready to understand your business goals.

Trusted Partners

Trusted by Industry Leaders Worldwide

Recognition

Awards & Recognitions

What Makes AI “Agentic”?

Agentic AI is distinguished from generative AI by three capabilities operating together.

Multi-step planning. The system decomposes a high-level goal (“draft this prior authorization letter”) into a sequence of sub-tasks (“retrieve the chart, identify the relevant clinical evidence, fetch the payer policy, check criteria, draft the narrative, attach supporting documentation”). Plans can branch, loop, and revise based on intermediate results.

Tool use. The system calls external tools — REST APIs, FHIR endpoints, payer portals, clinical databases, calculators, search systems — to gather information or take action. The LLM does not just generate text; it invokes capabilities the developer has registered as available tools.

Iteration based on intermediate results. The system evaluates what it learned from one tool call before deciding the next step. If the chart retrieval surfaces an unexpected diagnosis, the agent may pivot to a different policy lookup. If a tool call fails, the agent retries, falls back, or escalates to a human.

These three capabilities together unlock workflows that pure generative AI cannot — workflows where the answer depends on what the agent finds out partway through, and where the right next step is not knowable in advance. They also unlock failure modes that pure generative AI does not have, which is why the architecture is more involved.

Why Agentic AI Has Higher Stakes Than Generative AI in Healthcare

Three structural differences between agentic and generative AI matter operationally.

Tool calls take action, not just produce text. A generative AI failure produces a wrong piece of text that a human reviews and corrects. An agentic AI failure can submit a wrong claim, schedule a wrong appointment, send a wrong message to a patient, write a wrong record back to the EHR, or trigger a wrong workflow at a downstream system. The blast radius is larger, and unwinding the action is sometimes impossible.

Compliance surface multiplies across every tool. Generative AI has BAA requirements with the model provider. Agentic AI has BAA requirements with every system the agent calls — the EHR, the payer integration, the scheduling system, the intake platform, the patient-engagement tool, every downstream API in the agent’s tool set. The BAA paper trail is broader and the PHI flow map is more complex.

Failure modes are harder to evaluate and easier to compound. A generative model that hallucinates one fact in a discharge summary can be caught by a clinician reviewer. An agent that misinterprets a payer policy on step three of a fifteen-step workflow can produce a downstream error chain where every subsequent step compounds the original mistake. The eval methodology has to account for trajectory failures, not just point-in-time output quality.

This is why the architecture for production agentic AI in healthcare is structurally more conservative than what most agentic AI demos suggest. Tool-call allowlists, human-in-the-loop confirmation at consequential steps, deterministic guardrails on financial and clinical actions, and aggressive audit logging are not optional engineering decisions — they are the architecture.

Where Agentic AI Works in Healthcare in 2026

Five categories where agentic AI is delivering measurable production value in 2026. Each shares a structural property: the workflow has clear sub-steps, each step is auditable, and the consequential actions can be gated through human confirmation without breaking the value proposition.

Prior Authorization Automation

The agent receives a prior-auth request, retrieves the relevant chart context, looks up the payer’s coverage policy, evaluates criteria one-by-one against documented evidence, drafts the prior-auth letter, attaches supporting documentation, and presents the complete package to a clinician or PA-specialist for review and submission. Used in oncology, cardiology, advanced imaging, biologics, and any specialty with high prior-auth burden.

Why this works. The workflow is well-structured (retrieve evaluate draft submit), the sub-steps are auditable, the consequential action (submission) is gated through a human reviewer, and the value capture is large because clinician and nurse time on prior auth is enormous. Agent quality is measured against approval rates, denial-overturn rates, and clinician-time-saved-per-letter.

This use case extends the prior-auth copilot pattern with multi-step retrieval and evaluation — the engineering depth on the underlying productized clinical copilot pattern is the foundation.

Claims Status Follow-Up and Denials Management

The agent monitors claim status across payer systems, identifies denials and rejections, retrieves the necessary clinical and administrative context, drafts the appropriate response (corrected claim, appeal letter, reconsideration request), and presents it to a billing specialist for review. Used in revenue cycle, denials management, and accounts-receivable follow-up.

Why this works. The workflow is high-volume, well-structured, and operationally well-defined. The decision points (which denial to appeal, what evidence to include, when to escalate) follow established billing-specialist heuristics that can be encoded as tool-call patterns. Human review on the response keeps the consequential action (claim resubmission) gated.

Patient Scheduling and Pre-Visit Intake Orchestration

The agent receives an appointment request (from a portal, a referral, a phone-line transcription, a patient message), checks insurance eligibility, validates the referral, identifies the appropriate provider and visit type, finds available slots that meet patient and clinical constraints, drafts the appointment confirmation, and orchestrates the pre-visit intake (forms, prior-record requests, pre-visit testing). Some sub-steps are autonomous (eligibility check); consequential steps (final scheduling, patient communication) gate through a scheduler or are explicitly authorized by patient confirmation.

Why this works. The decisions that matter (which visit type, which provider, what insurance coverage) follow well-defined rules. The agent removes the operational tedium without making clinical decisions. Healthcare administrative workflows of this shape are also covered in our broader work on medical practice automation.

Referral Routing and Care Coordination

The agent receives a referral, identifies the appropriate specialty and sub-specialty, matches against the institution’s network and patient’s insurance, evaluates urgency from clinical context, drafts the referral package, and routes to the appropriate destination. Used in primary-care-to-specialty referrals, post-acute care transitions, and care-management coordination across health-system networks.

Why this works. The decisions are routing decisions, not clinical decisions. Urgency assessment uses well-defined heuristics. The agent compresses what is typically a multi-day care-coordinator workflow into hours, with the care coordinator providing the human-in-the-loop for clinically-judgment-bearing decisions.

Eligibility Verification and Benefits Investigation

The agent verifies insurance eligibility across payer systems, identifies the patient’s benefits structure for the relevant service, calculates patient financial responsibility, drafts good-faith estimates where required by regulation, and flags issues (lapsed coverage, prior-auth requirements, network considerations) for staff review. Used in revenue-cycle, financial counseling, and pre-service operational workflows.

Why this works. The workflow is deterministic-with-edge-cases. The agent handles the high-volume routine cases autonomously and escalates edge cases to staff. The consequential output (financial estimate to the patient) gates through staff review or follows a published policy. This pattern aligns closely with the broader AI automation in hospitals work, where similar operational-tedium use cases compound across larger organizational footprints.

The pattern across all five categories: structured workflows where the agent can plan, execute, and iterate; clear sub-step auditability; consequential actions gated through human review or deterministic guardrails; and value capture from clinician, nurse, or staff time saved on operational tedium that previously consumed disproportionate workforce hours.

Where Agentic AI Does Not Work in Healthcare

Four categories where agentic AI deployment is not appropriate today, and where attempting it has produced expensive failures across the industry.

Clinical decision-making in primary clinical workflows. An agent autonomously deciding diagnosis, treatment, or medication dosing crosses the FDA SaMD threshold immediately and represents both a regulatory and a patient-safety risk most healthcare organizations cannot accept. The architecture pattern that works is generative AI drafting clinical recommendations for clinician review (a copilot, not an agent). Agents that take autonomous clinical actions are not a 2026 deployment category for any organization that values its medical license.

High-stakes financial or legal actions without human review. Submitting claims, executing payments, signing legal documents, or any action with binding financial or legal effect is gated through human confirmation in production. Multi-million-dollar errors in agentic billing automation have become reference cases for why this gate is non-negotiable.

Patient-facing autonomous communication on clinical content. Direct-to-patient agentic communication (chatbots, message drafting, treatment-plan explanation) requires strong content-safety filters, hallucination guardrails, and — for any clinical claim — human review. Agents that send clinical content directly to patients without human gates have produced incidents that hospital risk-management teams now categorically avoid.

Workflows with unclear sub-step auditability. When an agent’s intermediate decisions cannot be inspected, validated, and reversed, the audit-trail and clinical-safety bar cannot be met. Agents that operate in this fashion are research demonstrations, not production deployments.

The decision framework: agentic AI works in well-structured operational workflows where the consequential decisions can be gated through human review and the intermediate steps can be audited. It does not work in unstructured clinical-judgment workflows or in any workflow where consequential actions cannot be reversed.

Section 05

The Production Architecture: Eight Required Capabilities

Every Taction agentic AI deployment includes these eight capabilities. The complexity beyond what generative AI requires reflects the larger compliance and safety surface of agentic systems.

1. Tool-call allowlist. The agent can only call tools the developer has explicitly registered. Tool registration includes the API contract, the authentication path, the rate limit, the BAA coverage status, and the consequential-action classification (read-only vs. mutating). Agents cannot call tools they have not been registered for; tool sprawl is one of the most common production failure modes and the allowlist eliminates it architecturally.

2. Deterministic guardrails on consequential actions. Mutating actions — anything that writes to the EHR, submits a claim, sends a message, schedules an appointment, transmits a record — passes through deterministic policy checks before execution. Policies cover authorization scope, value limits (no claim over $X, no scheduling beyond Y days), idempotency keys to prevent duplicate execution, and rate limits per workflow.

3. Human-in-the-loop confirmation at consequential steps. Every consequential action either requires explicit human confirmation or is governed by a documented policy that pre-authorizes the agent for the action class. The default is human-in-the-loop; pre-authorization is reserved for narrow, well-tested action categories where the policy is exhaustive and the audit trail captures every execution.

4. BAA paper trail spanning every tool. The agent’s compliance surface is the union of every system it calls. BAAs are required not just with the model provider but with every API endpoint that processes PHI on the agent’s behalf. The PHI flow map documents the agent’s full action surface, not just the model inference path.

5. Audit logging of every plan-execute-evaluate cycle. Every agent action is logged with the goal, the plan, the tool calls executed, the intermediate results observed, the decisions made, and the final action taken. Logs meet §164.312(b) and are retained per §164.530(j). Logs are queryable for retrospective audit — “show me every prior auth this agent submitted last quarter where the appeal was overturned.”

6. Trajectory evaluation methodology. Eval is harder for agents than for generative models because the right answer depends on the path, not just the output. Eval suites cover full trajectories — does the agent reach the right outcome via the right intermediate decisions, or does it reach the right outcome via a path that would fail under different inputs? Trajectory failures are caught in eval before they reach production.

7. Identity and access at the agent layer. The agent operates under a defined identity with defined permissions. Operations on behalf of a specific user inherit that user’s permissions, not the agent’s broader permissions. This is the architectural pattern that prevents privilege escalation through the agent.

8. Monitoring and incident response specific to agent failure modes. Anomaly detection on tool-call patterns (catching an agent that has started making unexpected tool calls). Drift detection on plan-quality metrics. Override rate tracking by workflow and by step. Incident-response runbooks specific to agentic failure modes (rogue tool calls, action loops, plan corruption).

These eight capabilities are the architecture. Specific deployments add capabilities — multi-tenant isolation for healthtech SaaS, on-prem deployment for hospitals that exclude cloud-hosted agents, FDA SaMD documentation where the agent’s outputs cross into regulated-device territory.

Production reality

Tool-Use Architecture: The Compliance Multiplier

The tool layer is where agentic AI creates compliance complexity that pure generative AI does not.

Read-only tools (FHIR read, payer eligibility check, clinical database lookup, calculation services). These tools fetch information without mutating state. BAA coverage applies wherever PHI flows. Audit logging captures every read for HIPAA’s “minimum necessary” tracking.

Mutating tools (FHIR write, claim submission, scheduling write, message send, EHR documentation write-back). These tools change state at downstream systems. BAA coverage, deterministic guardrails, idempotency keys, value limits, and human-in-the-loop confirmation (where applicable) all apply per tool. Mutating tool calls are first-class events in the audit log with full payload retention.

External-internet tools (web search, public-database lookup, regulatory-source check). These tools access information beyond the institution’s perimeter. Output must be evaluated for trustworthiness before incorporation into agent reasoning. PHI never leaves the perimeter through these tools — outbound queries are constructed to avoid embedding patient identifiers.

Tool-output handling. Tool outputs are treated as untrusted input from a security standpoint. Prompt-injection mitigation applies to tool outputs, not just user inputs — adversarial content embedded in a payer policy document or a retrieved record can attempt to manipulate the agent. The full architecture for this — including indirect prompt injection mitigation — is part of the HIPAA-compliant AI engineering practice and is built into every agentic deployment.

The tool-use layer is what makes agentic AI more powerful than generative AI — and what makes the architecture more demanding. Done right, the agent operates safely across a complex tool surface. Done wrong, the agent can take consequential actions in ways the operator did not authorize.

Pricing: Three Engagement Tiers

HIPAA + FHIR included. Always.

The Single-Workflow Agent tier is sized for healthtech founders or hospital innovation teams deploying their first agent in a defined workflow — most often prior-auth automation, claims-status follow-up, or scheduling orchestration. Deliverable is one agent workflow in production with the architecture (tool-call allowlist, guardrails, audit log, human-in-the-loop UX) built correctly.

The Multi-Workflow Production tier is sized for organizations deploying an agent into production with full multi-system integration scope and operational support — typical when the agent operates across the EHR, the payer integration, and one or more downstream systems.

The Enterprise Agent Platform tier covers the architecture for organizations deploying multiple agent workflows on shared infrastructure. The shared-infrastructure economics improve substantially when the tool registry, audit log, eval harness, and deterministic guardrails are built once and reused across agents.

For projects requiring on-prem deployment, multi-EHR or multi-payer integration scope, or specialty-specific workflow customization beyond the patterns above, pricing is custom. Use the healthcare engineering cost calculator for an estimate.

Build vs. Buy: When to Use a Specialist Partner for Agentic AI

The agentic AI commercial landscape in healthcare is younger than the generative or imaging landscape. Off-the-shelf products exist for narrow categories — prior-auth automation has multiple commercial products with documented track records, claims follow-up has several, eligibility verification has many — but the market is fragmented and rapidly evolving. The build-vs-buy decision turns on five factors.

Book a Discovery Call

What Makes Taction Different

Three things — verifiable.

Healthcare-only since 2013. 785+ healthcare implementations, 200+ EHR integrations, zero HIPAA findings on shipped software. Our healthcare engineering team has been building inside healthcare environments — including the EHR, payer, billing, scheduling, and clinical-system integrations agents call as tools — for over a decade. The depth shows up in the tool layer, where most generic agentic AI shops underdeliver.

Compliance-by-design across the agent’s full action surface. Most generic agent products handle the compliance surface for the LLM and miss the BAA paper trail across the tool layer. Our engagements scope the compliance surface for every tool the agent calls — BAAs, encryption, audit logging, RBAC — from week one. Our healthcare integration practice is the foundation for the multi-system integration depth.

The full agentic stack, including the safety architecture. Most generic agentic AI shops build the agent and skip the safety architecture. Our deployments include tool-call allowlists, deterministic guardrails, human-in-the-loop confirmation patterns, trajectory evaluation, and incident-response runbooks specific to agent failure modes. The bundle is what production agentic AI requires. Our broader hospital and health-system practice is the operational context.

The result: agentic AI we ship integrates with the systems clinicians and operations teams actually use, operates safely across consequential actions, passes HIPAA review on first audit, and continues running 18+ months after deployment without architectural drift.

Scope Your Agentic AI Engagement

If you are building agentic AI for your healthtech product, your hospital, or your health system, book a 60-minute scoping call. We will walk through the candidate workflow, the tool surface the agent will need to call, the consequential-action surface, the compliance posture, and the human-in-the-loop expectations — and tell you whether Single-Workflow Agent, Multi-Workflow Production, or Enterprise Agent Platform is the right starting point, and what 12–16 weeks of engineering will produce.